Expert perspectives on biosimilar monoclonal antibodies in breast cancer
about
A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.Biosimilars in rheumatology: what the clinician should know.Interchangeability of Biosimilars: A European Perspective.Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community.Effectiveness of biosimilar filgrastim vs. original granulocyte colony-stimulating factors in febrile neutropenia prevention in breast cancer patients.Comparing safety information of biosimilars with their originators: a cross-sectional analysis of European risk management plans.Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia.Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer.The evolution of biosimilars in oncology, with a focus on trastuzumab.Extrapolation concept at work with biosimilar: a decade of experience in oncology.EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
P2860
Q36396272-69F5209A-7771-4A74-A7BC-CDAFDD5931ACQ38300338-AE8A0A95-D40B-4A53-BA43-66C0DA8BFD74Q38618144-9A1AED7B-2F4D-4303-B1E7-5B743B78C6CBQ39000780-C8D55FC4-F6FD-4467-B03D-FB2F0717268EQ39260479-D6E59F1B-EB35-479B-96AF-33902B75FA2BQ47213188-166CB2E5-E981-42EB-B55F-8F0BC1E8876EQ48256716-1696D416-0843-4850-B64E-AA7CCDE2590BQ48307011-B987D3D7-AD50-453B-B075-B50AF1219340Q50001689-FDDCD7AD-5032-4EC4-841A-E842047C68FEQ55219324-1792862B-A5F6-4F88-8C00-735724423B30Q55384042-998CF6F4-41A0-4F98-AFD6-979E3593B58BQ58792200-91A1187F-B161-4293-80A3-E6E791089138
P2860
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@ast
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@en
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@nl
type
label
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@ast
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@en
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@nl
prefLabel
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@ast
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@en
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@nl
P2860
P921
P1476
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
@en
P2093
P2860
P2888
P304
P356
10.1007/S10549-014-2879-9
P407
P577
2014-04-01T00:00:00Z
P5875
P6179
1011088540